Cervical Cancer Trials
Select Clinical Trial
GOG 237: Comparative Analysis of CA-IX, p16, Proliferative Markers and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients with a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
- Women, ages 18 years or older, with confirmed atypical glandular cells (AGC) of the cervix. For additional criteria, call our Clinical Trials office at (910) 715-2200.